Review



nf kb ligand  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    MedChemExpress nf kb ligand
    In vitro osteoclastogenic differentiation and activation of RAW264.7 cells induced by t-MPN NPs. (A) Experimental timeline <t>of</t> <t>RANKL-induced</t> RAW264.7 cells cultured with t-MPN NPs on osteoclastogenic differentiation and activation. Cells treated with Sr, EGCG, and nt-MPN NPs were used for comparison. (B) TRAP staining of RAW264.7 cells cultured with different treatments for 7 days. Scale bars is 100 μm. (C) Quantitative analysis of the area (top) and viability (bottom) of TRAP-positive osteoclasts of RAW264.7 cells cultured with various treatments for 7 days. Scale bars are 50 μm. (D) F-actin (red)/nucleus (blue) staining of RAW264.7 cells cultured with different treatments on days 3 and 7. Scale bar is 50 μm. (E) Quantitative analysis of the osteoclasts number per 0.065 mm 2 area at day 7. (F) Expression of osteoclastogenic genes (TRAP, CTSK, MMP9, and NFATc1) in RAW264.7 cells determined by qRT-PCR analysis for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant.
    Nf Kb Ligand, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 87 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nf kb ligand/product/MedChemExpress
    Average 95 stars, based on 87 article reviews
    nf kb ligand - by Bioz Stars, 2026-03
    95/100 stars

    Images

    1) Product Images from "Regulation of Bone Remodeling by Metal–Phenolic Networks for the Treatment of Systemic Osteoporosis"

    Article Title: Regulation of Bone Remodeling by Metal–Phenolic Networks for the Treatment of Systemic Osteoporosis

    Journal: ACS Applied Materials & Interfaces

    doi: 10.1021/acsami.4c18829

    In vitro osteoclastogenic differentiation and activation of RAW264.7 cells induced by t-MPN NPs. (A) Experimental timeline of RANKL-induced RAW264.7 cells cultured with t-MPN NPs on osteoclastogenic differentiation and activation. Cells treated with Sr, EGCG, and nt-MPN NPs were used for comparison. (B) TRAP staining of RAW264.7 cells cultured with different treatments for 7 days. Scale bars is 100 μm. (C) Quantitative analysis of the area (top) and viability (bottom) of TRAP-positive osteoclasts of RAW264.7 cells cultured with various treatments for 7 days. Scale bars are 50 μm. (D) F-actin (red)/nucleus (blue) staining of RAW264.7 cells cultured with different treatments on days 3 and 7. Scale bar is 50 μm. (E) Quantitative analysis of the osteoclasts number per 0.065 mm 2 area at day 7. (F) Expression of osteoclastogenic genes (TRAP, CTSK, MMP9, and NFATc1) in RAW264.7 cells determined by qRT-PCR analysis for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant.
    Figure Legend Snippet: In vitro osteoclastogenic differentiation and activation of RAW264.7 cells induced by t-MPN NPs. (A) Experimental timeline of RANKL-induced RAW264.7 cells cultured with t-MPN NPs on osteoclastogenic differentiation and activation. Cells treated with Sr, EGCG, and nt-MPN NPs were used for comparison. (B) TRAP staining of RAW264.7 cells cultured with different treatments for 7 days. Scale bars is 100 μm. (C) Quantitative analysis of the area (top) and viability (bottom) of TRAP-positive osteoclasts of RAW264.7 cells cultured with various treatments for 7 days. Scale bars are 50 μm. (D) F-actin (red)/nucleus (blue) staining of RAW264.7 cells cultured with different treatments on days 3 and 7. Scale bar is 50 μm. (E) Quantitative analysis of the osteoclasts number per 0.065 mm 2 area at day 7. (F) Expression of osteoclastogenic genes (TRAP, CTSK, MMP9, and NFATc1) in RAW264.7 cells determined by qRT-PCR analysis for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant.

    Techniques Used: In Vitro, Activation Assay, Cell Culture, Comparison, Staining, Expressing, Quantitative RT-PCR



    Similar Products

    95
    MedChemExpress nf kb ligand
    In vitro osteoclastogenic differentiation and activation of RAW264.7 cells induced by t-MPN NPs. (A) Experimental timeline <t>of</t> <t>RANKL-induced</t> RAW264.7 cells cultured with t-MPN NPs on osteoclastogenic differentiation and activation. Cells treated with Sr, EGCG, and nt-MPN NPs were used for comparison. (B) TRAP staining of RAW264.7 cells cultured with different treatments for 7 days. Scale bars is 100 μm. (C) Quantitative analysis of the area (top) and viability (bottom) of TRAP-positive osteoclasts of RAW264.7 cells cultured with various treatments for 7 days. Scale bars are 50 μm. (D) F-actin (red)/nucleus (blue) staining of RAW264.7 cells cultured with different treatments on days 3 and 7. Scale bar is 50 μm. (E) Quantitative analysis of the osteoclasts number per 0.065 mm 2 area at day 7. (F) Expression of osteoclastogenic genes (TRAP, CTSK, MMP9, and NFATc1) in RAW264.7 cells determined by qRT-PCR analysis for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant.
    Nf Kb Ligand, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nf kb ligand/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    nf kb ligand - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    R&D Systems nf kb ligand rankl
    Monocytes isolated from mandible bone marrow have enhanced osteoclast differentiation. Bone marrow cells were flushed from mandibular and femoral bone and monocytes were selected for osteoclast cultures from 2–month–old mice. (A) Schematic illustrating procedure for selecting monocytes from bone marrow for osteoclast cultures; (B) representative TRAP–stained images of monocytes differentiated into osteoclasts in the presence of M-CSF and <t>RANKL</t> for 4 days. (C) Quantification of the number of TRAP positive multinuclear cells ( N ≥ 3). (D) Quantification of size of TRAP positive multinuclear cells. Scale bar is 10 mm.
    Nf Kb Ligand Rankl, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nf kb ligand rankl/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    nf kb ligand rankl - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology nf kb ligand
    Monocytes isolated from mandible bone marrow have enhanced osteoclast differentiation. Bone marrow cells were flushed from mandibular and femoral bone and monocytes were selected for osteoclast cultures from 2–month–old mice. (A) Schematic illustrating procedure for selecting monocytes from bone marrow for osteoclast cultures; (B) representative TRAP–stained images of monocytes differentiated into osteoclasts in the presence of M-CSF and <t>RANKL</t> for 4 days. (C) Quantification of the number of TRAP positive multinuclear cells ( N ≥ 3). (D) Quantification of size of TRAP positive multinuclear cells. Scale bar is 10 mm.
    Nf Kb Ligand, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nf kb ligand/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    nf kb ligand - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    90
    Ligand Pharmaceuticals receptor activator of nf-kb ligand 2024, 17, 1655 10 of 12
    Monocytes isolated from mandible bone marrow have enhanced osteoclast differentiation. Bone marrow cells were flushed from mandibular and femoral bone and monocytes were selected for osteoclast cultures from 2–month–old mice. (A) Schematic illustrating procedure for selecting monocytes from bone marrow for osteoclast cultures; (B) representative TRAP–stained images of monocytes differentiated into osteoclasts in the presence of M-CSF and <t>RANKL</t> for 4 days. (C) Quantification of the number of TRAP positive multinuclear cells ( N ≥ 3). (D) Quantification of size of TRAP positive multinuclear cells. Scale bar is 10 mm.
    Receptor Activator Of Nf Kb Ligand 2024, 17, 1655 10 Of 12, supplied by Ligand Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/receptor activator of nf-kb ligand 2024, 17, 1655 10 of 12/product/Ligand Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    receptor activator of nf-kb ligand 2024, 17, 1655 10 of 12 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Novoprotein recombinant mouse nf-kb receptor activator ligand (rankl)
    Monocytes isolated from mandible bone marrow have enhanced osteoclast differentiation. Bone marrow cells were flushed from mandibular and femoral bone and monocytes were selected for osteoclast cultures from 2–month–old mice. (A) Schematic illustrating procedure for selecting monocytes from bone marrow for osteoclast cultures; (B) representative TRAP–stained images of monocytes differentiated into osteoclasts in the presence of M-CSF and <t>RANKL</t> for 4 days. (C) Quantification of the number of TRAP positive multinuclear cells ( N ≥ 3). (D) Quantification of size of TRAP positive multinuclear cells. Scale bar is 10 mm.
    Recombinant Mouse Nf Kb Receptor Activator Ligand (Rankl), supplied by Novoprotein, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse nf-kb receptor activator ligand (rankl)/product/Novoprotein
    Average 90 stars, based on 1 article reviews
    recombinant mouse nf-kb receptor activator ligand (rankl) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    AUTODOCK GmbH docking of ligands like daidzein and genistein against nf-kb receptor
    Monocytes isolated from mandible bone marrow have enhanced osteoclast differentiation. Bone marrow cells were flushed from mandibular and femoral bone and monocytes were selected for osteoclast cultures from 2–month–old mice. (A) Schematic illustrating procedure for selecting monocytes from bone marrow for osteoclast cultures; (B) representative TRAP–stained images of monocytes differentiated into osteoclasts in the presence of M-CSF and <t>RANKL</t> for 4 days. (C) Quantification of the number of TRAP positive multinuclear cells ( N ≥ 3). (D) Quantification of size of TRAP positive multinuclear cells. Scale bar is 10 mm.
    Docking Of Ligands Like Daidzein And Genistein Against Nf Kb Receptor, supplied by AUTODOCK GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/docking of ligands like daidzein and genistein against nf-kb receptor/product/AUTODOCK GmbH
    Average 90 stars, based on 1 article reviews
    docking of ligands like daidzein and genistein against nf-kb receptor - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    AUTODOCK GmbH docking of ligands like hesperetin and eriodictoyl against nf-kb receptor
    Monocytes isolated from mandible bone marrow have enhanced osteoclast differentiation. Bone marrow cells were flushed from mandibular and femoral bone and monocytes were selected for osteoclast cultures from 2–month–old mice. (A) Schematic illustrating procedure for selecting monocytes from bone marrow for osteoclast cultures; (B) representative TRAP–stained images of monocytes differentiated into osteoclasts in the presence of M-CSF and <t>RANKL</t> for 4 days. (C) Quantification of the number of TRAP positive multinuclear cells ( N ≥ 3). (D) Quantification of size of TRAP positive multinuclear cells. Scale bar is 10 mm.
    Docking Of Ligands Like Hesperetin And Eriodictoyl Against Nf Kb Receptor, supplied by AUTODOCK GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/docking of ligands like hesperetin and eriodictoyl against nf-kb receptor/product/AUTODOCK GmbH
    Average 90 stars, based on 1 article reviews
    docking of ligands like hesperetin and eriodictoyl against nf-kb receptor - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Affinity Biosciences nf-kb ligand receptor activator (rankl)
    Monocytes isolated from mandible bone marrow have enhanced osteoclast differentiation. Bone marrow cells were flushed from mandibular and femoral bone and monocytes were selected for osteoclast cultures from 2–month–old mice. (A) Schematic illustrating procedure for selecting monocytes from bone marrow for osteoclast cultures; (B) representative TRAP–stained images of monocytes differentiated into osteoclasts in the presence of M-CSF and <t>RANKL</t> for 4 days. (C) Quantification of the number of TRAP positive multinuclear cells ( N ≥ 3). (D) Quantification of size of TRAP positive multinuclear cells. Scale bar is 10 mm.
    Nf Kb Ligand Receptor Activator (Rankl), supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nf-kb ligand receptor activator (rankl)/product/Affinity Biosciences
    Average 90 stars, based on 1 article reviews
    nf-kb ligand receptor activator (rankl) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    PeproTech human receptor activator nuclear factor (nf)-kb ligand (rankl
    Monocytes isolated from mandible bone marrow have enhanced osteoclast differentiation. Bone marrow cells were flushed from mandibular and femoral bone and monocytes were selected for osteoclast cultures from 2–month–old mice. (A) Schematic illustrating procedure for selecting monocytes from bone marrow for osteoclast cultures; (B) representative TRAP–stained images of monocytes differentiated into osteoclasts in the presence of M-CSF and <t>RANKL</t> for 4 days. (C) Quantification of the number of TRAP positive multinuclear cells ( N ≥ 3). (D) Quantification of size of TRAP positive multinuclear cells. Scale bar is 10 mm.
    Human Receptor Activator Nuclear Factor (Nf) Kb Ligand (Rankl, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human receptor activator nuclear factor (nf)-kb ligand (rankl/product/PeproTech
    Average 90 stars, based on 1 article reviews
    human receptor activator nuclear factor (nf)-kb ligand (rankl - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    In vitro osteoclastogenic differentiation and activation of RAW264.7 cells induced by t-MPN NPs. (A) Experimental timeline of RANKL-induced RAW264.7 cells cultured with t-MPN NPs on osteoclastogenic differentiation and activation. Cells treated with Sr, EGCG, and nt-MPN NPs were used for comparison. (B) TRAP staining of RAW264.7 cells cultured with different treatments for 7 days. Scale bars is 100 μm. (C) Quantitative analysis of the area (top) and viability (bottom) of TRAP-positive osteoclasts of RAW264.7 cells cultured with various treatments for 7 days. Scale bars are 50 μm. (D) F-actin (red)/nucleus (blue) staining of RAW264.7 cells cultured with different treatments on days 3 and 7. Scale bar is 50 μm. (E) Quantitative analysis of the osteoclasts number per 0.065 mm 2 area at day 7. (F) Expression of osteoclastogenic genes (TRAP, CTSK, MMP9, and NFATc1) in RAW264.7 cells determined by qRT-PCR analysis for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant.

    Journal: ACS Applied Materials & Interfaces

    Article Title: Regulation of Bone Remodeling by Metal–Phenolic Networks for the Treatment of Systemic Osteoporosis

    doi: 10.1021/acsami.4c18829

    Figure Lengend Snippet: In vitro osteoclastogenic differentiation and activation of RAW264.7 cells induced by t-MPN NPs. (A) Experimental timeline of RANKL-induced RAW264.7 cells cultured with t-MPN NPs on osteoclastogenic differentiation and activation. Cells treated with Sr, EGCG, and nt-MPN NPs were used for comparison. (B) TRAP staining of RAW264.7 cells cultured with different treatments for 7 days. Scale bars is 100 μm. (C) Quantitative analysis of the area (top) and viability (bottom) of TRAP-positive osteoclasts of RAW264.7 cells cultured with various treatments for 7 days. Scale bars are 50 μm. (D) F-actin (red)/nucleus (blue) staining of RAW264.7 cells cultured with different treatments on days 3 and 7. Scale bar is 50 μm. (E) Quantitative analysis of the osteoclasts number per 0.065 mm 2 area at day 7. (F) Expression of osteoclastogenic genes (TRAP, CTSK, MMP9, and NFATc1) in RAW264.7 cells determined by qRT-PCR analysis for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant.

    Article Snippet: CY5 and receptor activator of NF-kB ligand (RANKL/TNFSF11) were purchased from MedChemExpress (Shanghai, China).

    Techniques: In Vitro, Activation Assay, Cell Culture, Comparison, Staining, Expressing, Quantitative RT-PCR

    Monocytes isolated from mandible bone marrow have enhanced osteoclast differentiation. Bone marrow cells were flushed from mandibular and femoral bone and monocytes were selected for osteoclast cultures from 2–month–old mice. (A) Schematic illustrating procedure for selecting monocytes from bone marrow for osteoclast cultures; (B) representative TRAP–stained images of monocytes differentiated into osteoclasts in the presence of M-CSF and RANKL for 4 days. (C) Quantification of the number of TRAP positive multinuclear cells ( N ≥ 3). (D) Quantification of size of TRAP positive multinuclear cells. Scale bar is 10 mm.

    Journal: JBMR Plus

    Article Title: Mouse mandibular–derived osteoclast progenitors have differences in intrinsic properties compared with femoral–derived progenitors

    doi: 10.1093/jbmrpl/ziae029

    Figure Lengend Snippet: Monocytes isolated from mandible bone marrow have enhanced osteoclast differentiation. Bone marrow cells were flushed from mandibular and femoral bone and monocytes were selected for osteoclast cultures from 2–month–old mice. (A) Schematic illustrating procedure for selecting monocytes from bone marrow for osteoclast cultures; (B) representative TRAP–stained images of monocytes differentiated into osteoclasts in the presence of M-CSF and RANKL for 4 days. (C) Quantification of the number of TRAP positive multinuclear cells ( N ≥ 3). (D) Quantification of size of TRAP positive multinuclear cells. Scale bar is 10 mm.

    Article Snippet: Two days later, cells were refed with 1.5% CMG 14-12 culture supernatant and 5 ng/mL of receptor activator of NF-kB ligand (RANKL) (R and D Systems, catalog #462-TEC-010) to stimulate osteoclast differentiation.

    Techniques: Isolation, Staining

    Mandibular–derived osteoclast precursors proliferate less than femoral–derived osteoclast precursors and do not exhibit an increase in apoptosis activity. Bone marrow cells were flushed from the mandible and femur of 2–month–old C57Bl/6 mice and monocytes were selected. (A) Monocytes were grown in M-CSF for 4 days. CCK-8 activity was measured at 450 nm at plating (day 0) or after 4 days in M-CSF. (B) Osteoclast precursors were grown in M-CSF (day 0) or M-CSF and RANKL for 2 days (day 2). Apoptosis activity was quantified at day 0 or 2 using Promega Caspase-Glo 3/7 Assay. Graphed data represent Caspase-Glo3/7 activity normalized to the average number of nuclei in each culture condition ( N ≥ 3). Samples were compared using Student’s t -test.

    Journal: JBMR Plus

    Article Title: Mouse mandibular–derived osteoclast progenitors have differences in intrinsic properties compared with femoral–derived progenitors

    doi: 10.1093/jbmrpl/ziae029

    Figure Lengend Snippet: Mandibular–derived osteoclast precursors proliferate less than femoral–derived osteoclast precursors and do not exhibit an increase in apoptosis activity. Bone marrow cells were flushed from the mandible and femur of 2–month–old C57Bl/6 mice and monocytes were selected. (A) Monocytes were grown in M-CSF for 4 days. CCK-8 activity was measured at 450 nm at plating (day 0) or after 4 days in M-CSF. (B) Osteoclast precursors were grown in M-CSF (day 0) or M-CSF and RANKL for 2 days (day 2). Apoptosis activity was quantified at day 0 or 2 using Promega Caspase-Glo 3/7 Assay. Graphed data represent Caspase-Glo3/7 activity normalized to the average number of nuclei in each culture condition ( N ≥ 3). Samples were compared using Student’s t -test.

    Article Snippet: Two days later, cells were refed with 1.5% CMG 14-12 culture supernatant and 5 ng/mL of receptor activator of NF-kB ligand (RANKL) (R and D Systems, catalog #462-TEC-010) to stimulate osteoclast differentiation.

    Techniques: Derivative Assay, Activity Assay, CCK-8 Assay, Caspase-Glo Assay